EBITDA: Income before interest, taxes, depreciation and amortization.
Mustang Bio, Inc. (MBIO) had EBITDA of $-1.06M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-0.95M |
|
-- |
|
-- |
|
$1.06M |
|
$-1.06M |
|
$0.10M |
|
$-0.95M |
|
$-0.95M |
|
$-0.95M |
|
$-0.95M |
|
$-0.95M |
|
$-0.95M |
|
$-1.06M |
|
|
EBITDA |
$-1.06M |
6.73M |
|
6.73M |
|
$-0.14 |
|
$-0.14 |
|
| Balance Sheet Financials | |
$16.58M |
|
-- |
|
-- |
|
$16.58M |
|
$7.84M |
|
-- |
|
$0.15M |
|
$7.99M |
|
$8.60M |
|
$8.60M |
|
$8.60M |
|
7.58M |
|
| Cash Flow Statement Financials | |
$-1.01M |
|
-- |
|
-- |
|
$17.27M |
|
$16.26M |
|
$-1.01M |
|
$0.02M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.12 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.01M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-11.11% |
|
-11.11% |
|
-5.76% |
|
-11.11% |
|
$1.13 |
|
$-0.15 |
|
$-0.15 |
|